Literature DB >> 25033800

The allosteric switch and conformational states in Ras GTPase affected by small molecules.

Christian W Johnson1, Carla Mattos2.   

Abstract

Ras is a hub protein in signal transduction pathways leading to the control of cell proliferation, migration, and survival and a major target for drug discovery due to the presence of its mutants in about 20% of human cancers. Yet, the discovery of small molecules that can directly interfere with its function has been elusive in spite of intense efforts. This is most likely due to its highly flexible nature and the lack of a well-ordered active site. This chapter contains a discussion of our current understanding of conformational states in Ras-GTP, with focus on a recently discovered allosteric switch mechanism that may promote intrinsic hydrolysis of GTP in the presence of Raf. We discuss the manner in which small molecules are known to affect the equilibrium of states in Ras-GTP and suggest novel strategies to go forward in the search for inhibitors of this master signaling protein.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allosteric modulation; Allosteric networks; Binding site hot spots; FTMap; G domain; GTPase; MSCS; Oncogenic mutants; Protein conformation; Raf; Ras; Ras inhibitor; Ras intrinsic hydrolysis; Ras/Raf/MEK/ERK pathway

Mesh:

Substances:

Year:  2013        PMID: 25033800     DOI: 10.1016/B978-0-12-416749-0.00003-8

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  7 in total

Review 1.  Biology, pathology, and therapeutic targeting of RAS.

Authors:  J Matthew Rhett; Imran Khan; John P O'Bryan
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

2.  Predicting X-ray solution scattering from flexible macromolecules.

Authors:  Hao Zhou; Hugo Guterres; Carla Mattos; Lee Makowski
Journal:  Protein Sci       Date:  2018-10-16       Impact factor: 6.725

3.  Titration of ionizable groups in proteins using multiple neutron data sets from a single crystal: application to the small GTPase Ras.

Authors:  Ryan Knihtila; Alicia Y Volmar; Flora Meilleur; Carla Mattos
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-01-23       Impact factor: 1.056

4.  Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding.

Authors:  Pamela Y Ting; Christian W Johnson; Cong Fang; Xiaoqing Cao; Thomas G Graeber; Carla Mattos; John Colicelli
Journal:  FASEB J       Date:  2015-05-21       Impact factor: 5.191

5.  Unraveling a model of TCL/RhoJ allosterism using TC10 reverse chimeras.

Authors:  Rebecca R Florke; Grace T Young; Michael J Hamann
Journal:  Small GTPases       Date:  2017-10-03

6.  Delineating the RAS Conformational Landscape.

Authors:  Mitchell I Parker; Joshua E Meyer; Erica A Golemis; Roland L Dunbrack
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

Review 7.  Therapeutic targeting of RAS: New hope for drugging the "undruggable".

Authors:  Imran Khan; J Matthew Rhett; John P O'Bryan
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-10-31       Impact factor: 4.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.